Changes in Survival Over Time After a First Episode of Pneumocystis carinii Pneumonia for European Patients With Acquired Immunodeficiency Syndrome

Archives of Internal Medicine

Volumn 155, Issue 8, 1995, Pages 822-828

  Lundgren, Jens D ^a   Barton, Simon E ^b   Katlama, Christine ^c   Ledergerber, Bruno ^d   González Lahoz, Juan ^e   Pinching, Anthony J ^f   Proenca, Rui ^g   Hemmer, Robert ^h   Pedersen, Court ^a   Phillips, Andrew N ⁱ  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b St Stephen's Clinic   (United Kingdom)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d Swiss HIV Cohort Study   (Switzerland)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

^f ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^g HOSPITAL CURRY CABRAL   (Portugal)

^h Centre Hospitalier   (Luxembourg)

ⁱ ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BLOOD TRANSFUSION; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE CONTROL; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; PNEUMOCYSTIS PNEUMONIA; PREDICTION; PRIORITY JOURNAL; SURVIVAL RATE;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANALYSIS OF VARIANCE; EUROPE; FEMALE; HUMAN; LIFE TABLES; MALE; PNEUMONIA, PNEUMOCYSTIS CARINII; PROPORTIONAL HAZARDS MODELS; RISK; SUPPORT, NON-U.S. GOV'T; SURVIVAL RATE;

EID: 0028947040     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1995.00430080056008     Document Type: Article

References (23)

1. Masur H. Prevention and treatment of Pneumocystis pneumonia. N Engl J Med. 1992;327:1853-1859.
2. Rothenberg R, Woelfel M, Stoneburner R, Milberg J, Parker R, Truman B. Survival with the acquired immunodeficiency syndrome. N Engl J Med. 1987:317: 1297-1302.
3. Harris JE. Improved short-term survival of AIDS patients initially diagnosed with Pneumocystis carinii pneumonia, 1984 through 1987. JAMA. 1990;263:397-401.
4. Stehr-Green JK, Holman RC, Mahoney MA. Survival analysis of hemophiliaassociated AIDS cases in the U.S. Am J Public Health. 1989;79:832-835.
5. Bindels PJ, Poos RM, Jong JT, et al. Trends in mortality among AIDS patients in Amsterdam. AIDS. 1991;5:853-858.
6. Pedersen C, Gerstoft J, Tauris P, et al. Trends in survival of Danish AIDS patients. AIDS. 1990;4:1111-1116.
7. Peters BS, Beck EJ, Coleman DG, et al. Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: the changing face of AIDS. BMJ. 1991;302:203-207.
8. Jacobson LP, Kirby AJ, Phair JP, et al. Changes in survival after acquired immunodeficiency syndrome (AIDS): 1984-1991. Am J Epidemiol. 1993;138: 952-964.
9. Lundgren JD, Pedersen C, Clumeck N, et al. Survival differences in European AIDS patients, 1979-1989. BMJ. 1994;308:1068-1073.
10. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep. 1987; 36(suppl 1):3-15.
11. Kovacs JA, Hiemenz JW, Macher AM, et al. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med. 1984; 100:663-671.
12. Lundgren B, Lundgren JD, Nielsen T, Mathiesen L, Nielsen JO, Kovacs JA. Antibody responses to a major Pneumocystis carinii antigen in HIV infected patients with and without P carinii pneumonia. J Infect Dis. 1992;165:1151-1155.
13. Kales CP, Murren JR, Forres RA, Crocco JA. Early predictors of in-hospital morality for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Arch Intern Med. 1987;147:1413-1417.
14. Brenner F, Ognibene FP, Lack EE, et al. Prognostic factors and life expectancy of patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Am Rev Respir Dis. 1987;136:1199-1206.
15. Garay SM, Greene J. Prognostic indicators in the initial presentation of Pneumocystis carinii pneumonia. Chest. 1989;95:769-772.
16. Beck EJ, French PD, Helbert MH, et al. Improved outcome of Pneumocystis carinii pneumonia in AIDS patients: a multifactorial treatment effect. Int J STD AIDS. 1992;3:182-187.
17. Benfield TL, Hofmann B, Schattenkerk JKME, Jensen BN, Nielsen TL, Lundgren JD. A differential effect on serum neopterin and serum beta-2-microglobulin is induced by treatment in Pneumocystis carinii pneumonia. J Infect Dis. 1994; 169:1170-1173.
18. Bentsen KD, Nielsen TL, Schattenkerk JKME, Jensen BN, Lundgren JD. Type III procollagen in serum as marker of disease activity and prognosis in patients with Pneumocystis carinii infection. Am Rev Respir Dis. 1993;148:1558-1562.
19. The National Institutes of Health—University of California Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumocystis Pneumonia. Consensus statement on the use of corticosteroids as adjunctive therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. N Engl J Med. 1990;323:1500-1504.
20. MacFadden DK, Edelson JD, Hyland RH, Rodriguez CH, Inouye T, Rebuck AS. Corticosteroids as adjunctive therapy in treatment of Pneumocystis carinii pneumonia in patients with AIDS. Lancet. 1987;2:1477-1479.
21. Fischl MA, Richman DD, Grieco MH, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS related complex: a doubleblind, placebo-controlled trial. N Engl J Med. 1987;317:185-191.
22. Lundgren JD, Phillips AN, Pedersen C, et al. Comparison of the long-term prognosis of AIDS patients treated and not treated with zidovudine. JAMA. 1994; 271:1088-1092.
23. Tu JV, Biem HJ, Detsky AS. Bronchoscopy versus empirical therapy in HIV-infected patients with presumptive Pneumocystis carinii pneumonia. Am Rev Respir Dis. 1993;148:370-377.